chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Asthenia, Atelectasis, Atypical pneumonia
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test abnormal, Body temperature increased, COVID-19, Chills, Cholelithiasis
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Fibrin D dimer increased, Gallbladder disorder, Leukocytosis
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Nasopharyngitis, Nephrolithiasis, Pneumonitis, Pulmonary embolism
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary, Angiogram pulmonary abnormal, Anticoagulant therapy, Asthenia, Atelectasis
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atypical pneumonia, Blood test, Blood test abnormal, Body temperature, Body temperature increased
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chills, Cholelithiasis, Computerised tomogram, Computerised tomogram thorax
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Fibrin D dimer, Fibrin D dimer increased, Gallbladder disorder
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Leukocytosis, Malaise, Nasopharyngitis, Nephrolithiasis, Oxygen saturation
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonitis, Pulmonary embolism, Respiratory tract congestion, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: J&J Dose 4/1/21 (lot NA) COVID Positive 1/3/22  1/17/22: A 76-year-old male with a past medical history of type 2 DM, hypertension, CAD, OSA comes to ED complaining of not feeling well.  Patient states that for the past 2 weeks has been feeling sick.  Initially it started as cold and chills.  Complains of feeling congested, with mild cough which is nonproductive, but denies chest pain or shortness of breath.  Patient has been feeling progressively weak.  He took a home COVID-19 test, and tested positive. He received monoclonal antibody infusion on 01/05/202.  He received Johnson and Johnson COVID vaccine in April 2021, has not received booster dose. Yesterday he noted his oxygen saturation was below 90, could not get it about 90, which prompted him to come to the ED.  patient states he was taking ever make 10 and hydroxychloroquine prophylactically before he tested positive and also for a few days after the positive test.   In the ED his temp was 100.8° F, pulse ox was 89% on room air, now on 3 L oxygen by NC, saturating 94%.  Blood work is significant for leukocytosis and elevated D-dimer.  CT angio chest is done and is reported as right middle lobe pulmonary embolism without right heart strain, diffuse pneumonitis/atypical pneumonia versus subsegmental atelectasis.  CT chest also reported bilateral renal pelvic nephrolithiasis, cholelithiasis with distended gallbladder, and findings concerning for exophytic dorsal right posterior liver lobe neoplasia.   Patient was given IV ceftriaxone and Zithromax in the ED, anticoagulation with Lovenox is initiated.  1/20/22: P.o. zinc sulfate, vitamin-C and vitamin-D  P.o. Eliquis 10 mg b.i.d. for 7 days then 5 mg twice a day afterwards  Continue on home p.o. metformin and glimepiride  P.o. azithromycin course  P.o. Decadron course  Hemodynamically stable for discharge  Will discharge home  Follow-up with PCP in 3-5 days  Patient agrees with plan of care
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Admin Error
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered beyond use date.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was vaccinated with a COVID 19 Moderna Vaccine at the age of 17 yrs and 9 months   No adverse reaction to vaccine reported
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, COVID-19, Fatigue, Malaise, Oropharyngeal pain
Clinical narrative: COVID Break Through Case  I received my 1st booster shot on 12/20/2021  and My COVID  symptoms started on 03/24/2022 i tested positive for COVID. Runny nose, abdominal discomfort for 3 days , sore throat, allergy related issues  fever of 102, ( about a week).  After 10 days i started feeling better.  I took Tylenol  2 times a day. I also took vitamin C and Zinc.  I drank a lot of water and other fluids.  I took  care of it as like a bad  Flu. I still have stomach discomfort. and i still feel tired.  I also  caught COVID before any of my vaccines.  Am still recovering .
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Break Through Case  I received my 1st booster shot on 12/20/2021  and My COVID  symptoms started on 03/24/2022 i tested positive for COVID. Runny nose, abdominal discomfort for 3 days , sore throat, allergy related issues  fever of 102, ( about a week).  After 10 days i started feeling better.  I took Tylenol  2 times a day. I also took vitamin C and Zinc.  I drank a lot of water and other fluids.  I took  care of it as like a bad  Flu. I still have stomach discomfort. and i still feel tired.  I also  caught COVID before any of my vaccines.  Am still recovering .
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: admin error
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blood pressure increased, Dysarthria, Electrocardiogram, Facial paralysis
Clinical narrative: Patient was vaccinated at 9:20, answered no to the pre-vaccination questionnaire. At time of vaccination, patient's are swelled / induration on left deltoid muscle. Bled slightly, but stated she was taking blood thinners. Returned to check on pt and to give her an ice pack to place on her arm. Asked pt how she felt, stated she was feeling fine. Spoke to provider, who recommended we bring her back to an exam room to get her vitals. Upon walking back to room, pt was shaky, unsteady, and had slurred speech. Reported that she had several mini strokes in Dec. 2021 and seizures in March 2022.  Initially FAST positive for slurred speech, negative for facial droop. Pt does have history of series of mini strokes in December 2021.  Positive FAST second check 0955, slight droop L. side of face, speech problems, unsteady on feet. Called emergency at 0956. Pt received COVID vaccine Pt starting having symptoms of stroke at 0940. FAST test positive at 0945 for speech impairment, and at 0955 for minor facial droop. BP elevated at 191/61. Initially discussed meeting air support and discovered speaking with emergency dispatch that for some reason conditions didn't allow helicopters to come at this time. Unknown reasons for this decision. Pt would have to wait here and wait for medic support which would be up to 30 minutes longer, and then air support would be delayed unknown period of time. Pt departed with EMTs to hospital to meet air support at hospital.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site haemorrhage, Injection site induration, Injection site swelling, Nervousness, Neurological symptom
Clinical narrative: Patient was vaccinated at 9:20, answered no to the pre-vaccination questionnaire. At time of vaccination, patient's are swelled / induration on left deltoid muscle. Bled slightly, but stated she was taking blood thinners. Returned to check on pt and to give her an ice pack to place on her arm. Asked pt how she felt, stated she was feeling fine. Spoke to provider, who recommended we bring her back to an exam room to get her vitals. Upon walking back to room, pt was shaky, unsteady, and had slurred speech. Reported that she had several mini strokes in Dec. 2021 and seizures in March 2022.  Initially FAST positive for slurred speech, negative for facial droop. Pt does have history of series of mini strokes in December 2021.  Positive FAST second check 0955, slight droop L. side of face, speech problems, unsteady on feet. Called emergency at 0956. Pt received COVID vaccine Pt starting having symptoms of stroke at 0940. FAST test positive at 0945 for speech impairment, and at 0955 for minor facial droop. BP elevated at 191/61. Initially discussed meeting air support and discovered speaking with emergency dispatch that for some reason conditions didn't allow helicopters to come at this time. Unknown reasons for this decision. Pt would have to wait here and wait for medic support which would be up to 30 minutes longer, and then air support would be delayed unknown period of time. Pt departed with EMTs to hospital to meet air support at hospital.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder
Clinical narrative: Patient was vaccinated at 9:20, answered no to the pre-vaccination questionnaire. At time of vaccination, patient's are swelled / induration on left deltoid muscle. Bled slightly, but stated she was taking blood thinners. Returned to check on pt and to give her an ice pack to place on her arm. Asked pt how she felt, stated she was feeling fine. Spoke to provider, who recommended we bring her back to an exam room to get her vitals. Upon walking back to room, pt was shaky, unsteady, and had slurred speech. Reported that she had several mini strokes in Dec. 2021 and seizures in March 2022.  Initially FAST positive for slurred speech, negative for facial droop. Pt does have history of series of mini strokes in December 2021.  Positive FAST second check 0955, slight droop L. side of face, speech problems, unsteady on feet. Called emergency at 0956. Pt received COVID vaccine Pt starting having symptoms of stroke at 0940. FAST test positive at 0945 for speech impairment, and at 0955 for minor facial droop. BP elevated at 191/61. Initially discussed meeting air support and discovered speaking with emergency dispatch that for some reason conditions didn't allow helicopters to come at this time. Unknown reasons for this decision. Pt would have to wait here and wait for medic support which would be up to 30 minutes longer, and then air support would be delayed unknown period of time. Pt departed with EMTs to hospital to meet air support at hospital.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Product use issue
Clinical narrative: Vaccine administered beyond use date.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Aortic stenosis, Blood creatinine increased, Blood urea increased, COVID-19, Chest X-ray abnormal
Clinical narrative: Pfizer Dose 1 3/5/21 (EN6199); Pfizer Dose 2 3/31/21 (EN6207); Pfizer Dose 3 12/1/21 (FH8027); COVID Positive 3/10/22; 3/10/22: This is a 72-year-old female with history of type 2 diabetes mellitus, chronic kidney disease stage 4, hyperlipidemia, hypertension, sick sinus syndrome status post pacemaker placement in the past and monoclonal gammopathy who presented to the emergency department with shortness of breath and swelling in both legs. Patient states that her symptoms started about 2 weeks ago. She has been getting worsening dyspnea and she noted more edema in her legs than usual. She has no associated fever, chills, chest pain, nausea or vomiting. In the emergency department, patient was found to have a blood pressure of 168/92. Labs showed a creatinine of 6.4, BUN of 68, proBNP of 32636, troponin level of 0.79 with repeat of 0.74 hemoglobin of 9.1. Chest x-ray showed fluid overload. Patient received nebulizer treatment, p.o. aspirin, IV Lasix 80 mg. 3/16/22: Patient is a 72-year-old female who presented on 03/10/2022 with chief complaint of shortness of breath and bilateral lower extremity edema.  Symptoms had been progressing for 2 weeks.  Creatinine was 6.4 on arrival. Patient was noted to be in fluid volume overload. Echocardiogram showed EF of 60-65%.  There was also mention of severe aortic stenosis and moderate to severe mitral regurg.  On admission, it was thought that her symptoms were secondary to progression of her baseline stage IV CKD. She already had had a fistula placed in her right forearm prior to admission in anticipation that she would need dialysis in the near future.  Patient was started on HD. She tolerated this well.  Patient felt overall improved from time of admission.  An outpatient dialysis chair was arranged.  She was therefore discharged on 03/16/2022. Prior to her discharge, we did have a risks/benefits discussion about staying in the hospital for cardiology consultation and workup for possible TAVR.  Through shared decision making, it was felt reasonable to have the patient follow-up as an outpatient within the next week or so since she was overall doing better.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Ejection fraction, Haemodialysis, Haemoglobin normal
Clinical narrative: Pfizer Dose 1 3/5/21 (EN6199); Pfizer Dose 2 3/31/21 (EN6207); Pfizer Dose 3 12/1/21 (FH8027); COVID Positive 3/10/22; 3/10/22: This is a 72-year-old female with history of type 2 diabetes mellitus, chronic kidney disease stage 4, hyperlipidemia, hypertension, sick sinus syndrome status post pacemaker placement in the past and monoclonal gammopathy who presented to the emergency department with shortness of breath and swelling in both legs. Patient states that her symptoms started about 2 weeks ago. She has been getting worsening dyspnea and she noted more edema in her legs than usual. She has no associated fever, chills, chest pain, nausea or vomiting. In the emergency department, patient was found to have a blood pressure of 168/92. Labs showed a creatinine of 6.4, BUN of 68, proBNP of 32636, troponin level of 0.79 with repeat of 0.74 hemoglobin of 9.1. Chest x-ray showed fluid overload. Patient received nebulizer treatment, p.o. aspirin, IV Lasix 80 mg. 3/16/22: Patient is a 72-year-old female who presented on 03/10/2022 with chief complaint of shortness of breath and bilateral lower extremity edema.  Symptoms had been progressing for 2 weeks.  Creatinine was 6.4 on arrival. Patient was noted to be in fluid volume overload. Echocardiogram showed EF of 60-65%.  There was also mention of severe aortic stenosis and moderate to severe mitral regurg.  On admission, it was thought that her symptoms were secondary to progression of her baseline stage IV CKD. She already had had a fistula placed in her right forearm prior to admission in anticipation that she would need dialysis in the near future.  Patient was started on HD. She tolerated this well.  Patient felt overall improved from time of admission.  An outpatient dialysis chair was arranged.  She was therefore discharged on 03/16/2022. Prior to her discharge, we did have a risks/benefits discussion about staying in the hospital for cardiology consultation and workup for possible TAVR.  Through shared decision making, it was felt reasonable to have the patient follow-up as an outpatient within the next week or so since she was overall doing better.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hypervolaemia, Mitral valve incompetence, Oedema peripheral, Peripheral swelling, Prohormone brain natriuretic peptide
Clinical narrative: Pfizer Dose 1 3/5/21 (EN6199); Pfizer Dose 2 3/31/21 (EN6207); Pfizer Dose 3 12/1/21 (FH8027); COVID Positive 3/10/22; 3/10/22: This is a 72-year-old female with history of type 2 diabetes mellitus, chronic kidney disease stage 4, hyperlipidemia, hypertension, sick sinus syndrome status post pacemaker placement in the past and monoclonal gammopathy who presented to the emergency department with shortness of breath and swelling in both legs. Patient states that her symptoms started about 2 weeks ago. She has been getting worsening dyspnea and she noted more edema in her legs than usual. She has no associated fever, chills, chest pain, nausea or vomiting. In the emergency department, patient was found to have a blood pressure of 168/92. Labs showed a creatinine of 6.4, BUN of 68, proBNP of 32636, troponin level of 0.79 with repeat of 0.74 hemoglobin of 9.1. Chest x-ray showed fluid overload. Patient received nebulizer treatment, p.o. aspirin, IV Lasix 80 mg. 3/16/22: Patient is a 72-year-old female who presented on 03/10/2022 with chief complaint of shortness of breath and bilateral lower extremity edema.  Symptoms had been progressing for 2 weeks.  Creatinine was 6.4 on arrival. Patient was noted to be in fluid volume overload. Echocardiogram showed EF of 60-65%.  There was also mention of severe aortic stenosis and moderate to severe mitral regurg.  On admission, it was thought that her symptoms were secondary to progression of her baseline stage IV CKD. She already had had a fistula placed in her right forearm prior to admission in anticipation that she would need dialysis in the near future.  Patient was started on HD. She tolerated this well.  Patient felt overall improved from time of admission.  An outpatient dialysis chair was arranged.  She was therefore discharged on 03/16/2022. Prior to her discharge, we did have a risks/benefits discussion about staying in the hospital for cardiology consultation and workup for possible TAVR.  Through shared decision making, it was felt reasonable to have the patient follow-up as an outpatient within the next week or so since she was overall doing better.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin
Clinical narrative: Pfizer Dose 1 3/5/21 (EN6199); Pfizer Dose 2 3/31/21 (EN6207); Pfizer Dose 3 12/1/21 (FH8027); COVID Positive 3/10/22; 3/10/22: This is a 72-year-old female with history of type 2 diabetes mellitus, chronic kidney disease stage 4, hyperlipidemia, hypertension, sick sinus syndrome status post pacemaker placement in the past and monoclonal gammopathy who presented to the emergency department with shortness of breath and swelling in both legs. Patient states that her symptoms started about 2 weeks ago. She has been getting worsening dyspnea and she noted more edema in her legs than usual. She has no associated fever, chills, chest pain, nausea or vomiting. In the emergency department, patient was found to have a blood pressure of 168/92. Labs showed a creatinine of 6.4, BUN of 68, proBNP of 32636, troponin level of 0.79 with repeat of 0.74 hemoglobin of 9.1. Chest x-ray showed fluid overload. Patient received nebulizer treatment, p.o. aspirin, IV Lasix 80 mg. 3/16/22: Patient is a 72-year-old female who presented on 03/10/2022 with chief complaint of shortness of breath and bilateral lower extremity edema.  Symptoms had been progressing for 2 weeks.  Creatinine was 6.4 on arrival. Patient was noted to be in fluid volume overload. Echocardiogram showed EF of 60-65%.  There was also mention of severe aortic stenosis and moderate to severe mitral regurg.  On admission, it was thought that her symptoms were secondary to progression of her baseline stage IV CKD. She already had had a fistula placed in her right forearm prior to admission in anticipation that she would need dialysis in the near future.  Patient was started on HD. She tolerated this well.  Patient felt overall improved from time of admission.  An outpatient dialysis chair was arranged.  She was therefore discharged on 03/16/2022. Prior to her discharge, we did have a risks/benefits discussion about staying in the hospital for cardiology consultation and workup for possible TAVR.  Through shared decision making, it was felt reasonable to have the patient follow-up as an outpatient within the next week or so since she was overall doing better.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Pain, Syncope
Clinical narrative: then day of the shot patient had chills, sweats, body aches, and fainted. Symptoms resolved the next day.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Oedema peripheral, Pain
Clinical narrative: Fever, body ache, joint ache, brain fog, tiredness, and a bubble of fluid in my underarm on the shot arm.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever, body ache, joint ache, brain fog, tiredness, and a bubble of fluid in my underarm on the shot arm.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered beyond use date.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: PT lives at at nursing home; pt had a positive COVID test on 11/23/21 in the nursing home; placed in isolation; DNR; comfort measures; pt passed away in the nursing home.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Redness, soreness, and swelling at injection site, approximately 2cm in width
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: pt. vaccinated at a local outreach. vaccine provided based on database records at the time of vaccine. pt. presented without vaccine card. booster given too close to primary series. recommended interval was not met. pt. was vaccinated 2 days apart.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Head discomfort, Nasal congestion, Paranasal sinus discomfort, Productive cough
Clinical narrative: Tested Positive for Covid on June 13.  Sympoms were like sinus, head pressure, stuffy nose, Cough with clear phlegm.  No fever.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid on June 13.  Sympoms were like sinus, head pressure, stuffy nose, Cough with clear phlegm.  No fever.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Product use issue
Clinical narrative: Vaccine administered beyond use date.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product use issue
Clinical narrative: Vaccine administered beyond use date.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Colitis, Influenza virus test negative, Multisystem inflammatory syndrome, SARS-CoV-2 test positive
Clinical narrative: I had multisymptom inflammatory syndrome that lasted about a month, beginning in April of 2022. I went to urgent care on April 22, 2022, the day I had the positive COVID-19 test.  I was already on steroids for Colitis, which I think helped, over the counter decongestants and Tylenol. They did prescribe Paxlovid but my pharmacy did not have it.  The doctor said if I got worse to pick up the script.  I never did pick it up or take it.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute left ventricular failure, COVID-19, Cardiac failure congestive, Death, SARS-CoV-2 test positive
Clinical narrative: per our records, pt had a positive COVID test on 1/18/22 with the ordering facility being Hospital; requested records, but they did not find records of pt between 1/12/22 - 2/1/22; per death certificate, pt passed away of acute diastolic congestive heart failure and COVID 19 viral infection; attempted to get a fax number to request records but the phone line continued to be busy, I tried for 2 days.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Product use issue
Clinical narrative: Vaccine administered beyond use date.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond use date.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Hypertension
Clinical narrative: 1/21/21 received first Moderna vaccine, no long standing adverse side effects. Received second Moderna vaccine 2/17/21. no adverse side effects. Received Moderna booster 09/01/2021 and around. 2 months afterwards suddenly developed Hypertension. With medication was controlled on dosages of medications taken. Received Moderna 4th shot  or second booster Mat 18,2022 and on June 15th Hypertension not controlled anymore and needed increased dosage of meds. After my first booster hypertension started but became controlled with meds but after second booster, the hypertension increased again. There was no change in anything else in my life except the booster shot given. I discussed this my cardiologist and he agreed that.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy
Clinical narrative: swollen lymph nodes and headache
Age: 21.0
Sex: F
Vaccine: HEP
Symptoms: No adverse event
Clinical narrative: No adverse event or reaction
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, Death
Clinical narrative: 12/31/2022 pt had a positive COVID test in Healthcare Center; DNR; 01/05/2022 pt went to ED at Hospital for SOB; per death certificate, pt expired at her house with causes of death being acute on chronic hypoxia and hypercapneic respiratory failure, exacerbation of COPD at end stage, and COVID 19 infection;
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: 12/31/2022 pt had a positive COVID test in Healthcare Center; DNR; 01/05/2022 pt went to ED at Hospital for SOB; per death certificate, pt expired at her house with causes of death being acute on chronic hypoxia and hypercapneic respiratory failure, exacerbation of COPD at end stage, and COVID 19 infection;
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: 12 year patient was administered a pediatric dose Pfizer.  After mistake was noticed, situation was explained to mother. Reviewed data, ok to give correct dose today. Mother informed and agreeable to plan.
Age: 7.0
Sex: M
Vaccine: HPV9
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine was administered  at a not recommended age.
Age: 12.0
Sex: F
Vaccine: HPV9, TDAP
Symptoms: Dizziness, Pallor
Clinical narrative: Patient felt faint after immunizations. Assisted pt to the floor, elevated feet, cold  cloths applied to pt and fanned her. Other RNs assisted as well. BP taken 116/65  with pulse of 87. Pt sat up for about 5-10 minutes before attempting to stand  with help. Pt gained her color back to her face and stated she felt better.  Mother reported child had not eaten before coming in today. Advised pt to wait  in the waiting room for an additional 10-15 min to be sure she felt okay.  Pt was fine when she left clinic.
Age: 2.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Drug screen negative, Hallucination, visual, Psychotic disorder, Specific gravity urine normal, pH urine normal
Clinical narrative: Patient developed sudden onset hallucinations (visual, possibly auditory) and psychosis beginning 6 hours after vaccination and lasting for 7 hours, then fell asleep. Reawakened with more hallucinations/psychosis 16 hours after vaccination (6 am today) lasting for another 1.5 hours. Transported to Pediatric ED where psychosis/hallucinations resolved. Examination normal. Remained at baseline (normal) upon discharge from ED.
Age: 2.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abnormal behaviour, Hallucination
Clinical narrative: Patient developed sudden onset hallucinations (visual, possibly auditory) and psychosis beginning 6 hours after vaccination and lasting for 7 hours, then fell asleep. Reawakened with more hallucinations/psychosis 16 hours after vaccination (6 am today) lasting for another 1.5 hours. Transported to Pediatric ED where psychosis/hallucinations resolved. Examination normal. Remained at baseline (normal) upon discharge from ED.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: NO ADVERSE EFFECT REPORTED .   PATIENT IS 2 YEARS OLD  .. LOCAL LAW/PROTOCOL ALLOWS PHARMACIST TO VACCINATE KIDS AGE 3 AND UP
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia, Arthralgia, Fatigue, Pallor, Vaccination site pain
Clinical narrative: Extreme pain to vaccination site.  Circular margin at injection site approximately 1 1/2 inches across, blanched  and hair loss in a portion of the margin.  Also complained of extreme joint pain and fatigue.  Pain at injection site progressively worse with each dose.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Peripheral swelling
Clinical narrative: SWOLLEN LEG, RED MARK AROUND THE AREA.